These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35080151)

  • 21. Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts.
    Dodge GR; Hawkins D; Boesler E; Sakai L; Jimenez SA
    Osteoarthritis Cartilage; 1998 Nov; 6(6):435-40. PubMed ID: 10343777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of monoclonal antibodies recognizing different fragments of cartilage oligomeric matrix protein in human body fluids.
    Vilim V; Lenz ME; Vytasek R; Masuda K; Pavelka K; Kuettner KE; Thonar EJ
    Arch Biochem Biophys; 1997 May; 341(1):8-16. PubMed ID: 9143347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evidence of cartilaginous benefit of treatment with infliximab in rheumatoid arthritis using measurement of serum COMP].
    Yamamoto M; Takahashi H; Ohara M; Suzuki C; Naishiro Y; Yamamoto H; Shinomura Y; Imai K
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Feb; 30(1):41-7. PubMed ID: 17332704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum and synovial cartilage oligomeric matrix protein levels in early and established rheumatoid arthritis.
    El Defrawy AO; Gheita TA; Raslan HM; El Ansary MM; El Awar AH
    Z Rheumatol; 2016 Nov; 75(9):917-923. PubMed ID: 26683321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels of cartilage oligomeric matrix protein (COMP): a rapid decrease in patients with active rheumatoid arthritis undergoing intravenous steroid treatment.
    Skoumal M; Haberhauer G; Feyertag J; Kittl EM; Bauer K; Dunky A
    Rheumatol Int; 2006 Sep; 26(11):1001-4. PubMed ID: 16485108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and its correlation with sonographic knee cartilage thickness and disease activity.
    Sakthiswary R; Rajalingam S; Hussein H; Sridharan R; Asrul AW
    Clin Rheumatol; 2017 Dec; 36(12):2683-2688. PubMed ID: 28889184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of circadian rhythm, age, training and acute lameness on serum concentrations of cartilage oligomeric matrix protein (COMP) neo-epitope in horses.
    Ekman S; Lindahl A; Rüetschi U; Jansson A; Björkman K; Abrahamsson-Aurell K; Björnsdóttir S; Löfgren M; Hultén LM; Skiöldebrand E
    Equine Vet J; 2019 Sep; 51(5):674-680. PubMed ID: 30739342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. (Auto)immunity to cartilage matrix proteins - a time bomb?
    Kinne RW
    Arthritis Res Ther; 2013 Jan; 15(1):101. PubMed ID: 23336107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rheumatoid arthritis sera antibodies to citrullinated collagen type II bind to joint cartilage.
    Li Q; Li Y; Liang B; Xu R; Xu B; Lönnblom E; Feng H; Bai J; Stawikowska R; Ge C; Lu A; Fields GB; Xiao L; Holmdahl R
    Arthritis Res Ther; 2022 Nov; 24(1):257. PubMed ID: 36419093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab.
    Nakajima S; Naruto T; Miyamae T; Imagawa T; Mori M; Nishimaki S; Yokota S
    Mod Rheumatol; 2009; 19(1):42-6. PubMed ID: 18726067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cartilage and bone loss in premenopausal women with rheumatoid arthritis: Radiological and laboratory assessments.
    Elsawy NA; Ghazala RA; Elnemr R
    Int J Rheum Dis; 2023 Nov; 26(11):2195-2205. PubMed ID: 37731289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cartilage Oligomeric Matrix Protein Induced Arthritis-A New Model for Rheumatoid Arthritis in the C57BL/6 Mouse.
    Zhao Y; Urbonaviciute V; Xu B; Cai W; Sener Z; Ge C; Holmdahl R
    Front Immunol; 2021; 12():631249. PubMed ID: 33708221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of cartilage oligomeric matrix protein (COMP) in synovial fibroblasts and synovial fluids.
    Hummel KM; Neidhart M; Vilim V; Hauser N; Aicher WK; Gay RE; Gay S; Häuselmann HJ
    Br J Rheumatol; 1998 Jul; 37(7):721-8. PubMed ID: 9714346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cartilage oligomeric matrix protein deficiency promotes early onset and the chronic development of collagen-induced arthritis.
    Geng H; Carlsen S; Nandakumar KS; Holmdahl R; Aspberg A; Oldberg A; Mattsson R
    Arthritis Res Ther; 2008; 10(6):R134. PubMed ID: 19014566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of cartilage oligomeric matrix protein (COMP) degradation and synthesis in equine joint disease.
    Arai K; Misumi K; Carter SD; Shinbara S; Fujiki M; Sakamoto H
    Equine Vet J; 2005 Jan; 37(1):31-6. PubMed ID: 15651731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis.
    Markovics A; Ocskó T; Katz RS; Buzás EI; Glant TT; Mikecz K
    PLoS One; 2016; 11(7):e0160284. PubMed ID: 27466816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cartilage oligomeric matrix protein forms protein complexes with synovial lubricin via non-covalent and covalent interactions.
    Flowers SA; Kalamajski S; Ali L; Björkman LI; Raj JR; Aspberg A; Karlsson NG; Jin C
    Osteoarthritis Cartilage; 2017 Sep; 25(9):1496-1504. PubMed ID: 28373131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of cartilage oligomeric matrix protein (COMP) and a COMP neoepitope in synovial fluid of patients with different joint disorders by novel automated assays.
    Lorenzo P; Aspberg A; Saxne T; Önnerfjord P
    Osteoarthritis Cartilage; 2017 Sep; 25(9):1436-1442. PubMed ID: 28473207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of antibodies against extracellular matrix proteins in human osteoarthritis.
    Ruthard J; Hermes G; Hartmann U; Sengle G; Pongratz G; Ostendorf B; Schneider M; Höllriegl S; Zaucke F; Wagener R; Streichert T; Klatt AR
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1273-1277. PubMed ID: 30001809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of leflunomide therapy on the activity of matrixmetalloproteinase-9 and the release of cartilage oligomeric matrix protein in patients with rheumatoid arthritis.
    Kullich WC; Mur E; Aglas F; Niksic F; Czerwenka C
    Clin Exp Rheumatol; 2006; 24(2):155-60. PubMed ID: 16762150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.